SCHEMBL19949458

SCHEMBL19949458

CC(c1c(N)ccnc1C#N)N1CCOCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.37
ALDH1A1 P00352 7/20 0.35
KDM4E B2RXH2 5/20 0.34
LMNA P02545 3/20 0.34
KCNMA1 Q12791 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.33
ROCK2 O75116 1/20 0.33
ROCK1 Q13464 1/20 0.33
CDC42BPB Q9Y5S2 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33
HPGD P15428 3/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CTSK P43235 1/20 0.33
TBK1 Q9UHD2 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19949436 0.84 ALDH1A1 (0.36) GAAALDH1A1KDM4ELMNAKCNMA1
SCHEMBL19949459 0.82 GAA (0.37) GAAALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL19949448 0.75 ATR (0.47) ALDH1A1PIK3CAAAK1
SCHEMBL2711245 0.73 KDM4E (0.43) GAAALDH1A1KDM4ELMNAKCNMA1
SCHEMBL19949437 0.71 ALDH1A1 (0.38) GAAALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL4929750 0.68 TSHR (0.40) ALDH1A1LMNASMN1; SMN2PIK3CAHSD17B10
SCHEMBL6071996 0.67 ADORA2A (0.46) GAAALDH1A1KDM4ESMN1; SMN2PIK3CD
SCHEMBL16272261 0.65 KCNA5 (0.45) GAAALDH1A1KDM4EHSD17B10L3MBTL1
SCHEMBL18108807 0.64 ALDH1A1 (0.41) ALDH1A1KDM4ELMNASMN1; SMN2AAK1
SCHEMBL7745378 0.63 DPP4 (0.46) ALDH1A1LMNASMN1; SMN2AAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10538491-B2 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators VANDERBILT UNIVERSITY (US) 2020-01-21 US disclosed
US-20180072674-A1 NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 VANDERBILT UNIVERSITY (US) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10538491-B2 4,5-substituted picolinamide and picolinonitrile metabotropic glutamate receptor 2 negative allosteric modulators GRM2, GRIA2, GRIN2A GAA 3835/4885ALDH1A1 3137/4885KDM4E 2605/4885
US-20180072674-A1 NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 GRM2, GRM1, GRIN2A GAA 2565/4885ALDH1A1 4190/4885KDM4E 1979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.